Neuralstem Inc. Reports 2007 Third Quarter Financial Results ...(centive bonus plan. Non-operating inc...),Health

Non-operating income (expense) for the nine month period ending September 30, 2007 and 2006 were $135,390, and $(4,029), respectively. The largest factor influencing the increase in 2007 relates to interest income derived from our higher cash deposit balance compared to prior period.

STATEMENTS OF OPERATIONS

Three Months Ended Nine Months Ended

Sept 30, Sept. 30,

2007 2006 2007 2006

Revenues $45,733 $150,072 $306,057 $209,283

Operating expenses

Research and development

costs 672,101 422,794 2,202,670 1,247,386

General, selling and

administrative expenses 832,348 311,932 2,359,515 763,664

Depreciation and

amortization 22,403 12,154 48,365 38,942

1,526,852 746,880 4,610,550 2,049,992

Operating loss (1,481,119) (596,808) (4,304,493)(1,840,709)

Nonoperating income (expense)

Interest 59,397 24,218 136,358 61,381

Interest expense (298) (394) (968) (9,090)

Reversal of Loss related

to adjustment of warrants

liability to fair value - 388,401 - -

Other expense - (26,505) - (56,320)

Net loss (1,422,020) (211,088) (4,169,103)(1,844,738)

Net loss per share,

basic (0.05) (0.01) (0.15) (0.08)

Average number of

shares of common

stock outstanding 29,372,895 25,608,272 28,370,589 24,591,149

BALANCE SHEET

'/>"/>